Overview of drug data within French health insurance databases and implications for pharmacoepidemiological studies-Reference-Cited by-同舟云学术

Overview of drug data within French health insurance databases and implications for pharmacoepidemiological studies

Published:2016-07-13 Issue:6 Volume:30 Page:616-624
ISSN:0767-3981
Container-title:Fundamental & Clinical Pharmacology
language:en
Short-container-title:Fundam Clin Pharmacol

Author:

Palmaro Aurore¹²³^ORCID,Moulis Guillaume¹²³⁴,Despas Fabien¹²³,Dupouy Julie²⁵,Lapeyre-Mestre Maryse¹²³

Affiliation:

1. Medical and Clinical Pharmacology Unit; CHU Toulouse University Hospital; 37, Allées Jules Guesde 31000 Toulouse France

2. Pharmacoepidemiology Research Unit; INSERM 1027; University of Toulouse; 37, Allées Jules Guesde 31000 Toulouse France

3. CIC 1436; Toulouse University Hospital; Place du Docteur Baylac - TSA 40031 31059 Toulouse Cedex 9 France

4. Department of Internal Medicine; Toulouse University Hospital; Place du Docteur Baylac - TSA 40031 31059 Toulouse Cedex 9 France

5. Academic Department of Family Medicine; Faculty of Medicine Toulouse; University of Toulouse; 133 route de Narbonne 31062 Toulouse France

Funder

Agence Nationale de la Recherche

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/fcp.12214/fullpdf

Reference33 articles.

1. Data management and data analysis techniques in pharmacoepidemiological studies using a pre-planned multi-database approach: a systematic literature review;Bazelier;Pharmacoepidemiol. Drug Saf.,2015

2. The European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) Guide on Methodological Standards in Pharmacoepidemiology (EMA/95098/2010 Rev. 4) http://www.encepp.eu/standards_and_guidances/documents/ENCePPGuideofMethStandardsinPE_Rev4.pdf

3. A review of uses of health care utilization databases for epidemiologic research on therapeutics;Schneeweiss;J. Clin. Epidemiol.,2005

4. Using secondary data sources for pharmacoepidemiology and outcomes research;Harpe;Pharmacotherapy,2009

5. Guidelines for good database selection and use in pharmacoepidemiology research;Hall;Pharmacoepidemiol. Drug Saf.,2012

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of the French National Health Data System (SNDS) in pharmacoepidemiology: A systematic review in its maturation phase;Therapies;2024-05

2. Triptan use in elderly over 65 years and the risk of hospitalization for serious vascular events;The Journal of Headache and Pain;2024-04-26

3. The French ecology of medical care. A nationwide population-based cross sectional study;Family Practice;2023-11-02

4. Temporal Trends in Pacemaker Implantations Over the Past Decade in France: Impact of Transcatheter Aortic Valve Implantations;The American Journal of Cardiology;2023-09

5. Drug–drug interactions of protein kinase inhibitors in chronic myeloid leukaemia patients: A study using the French health insurance database;Fundamental & Clinical Pharmacology;2023-04-24